Blog Posts in April, 2014
Posted on Apr 28, 2014 By The Senators (Ret.) Firm
Four months ago, the U.S. Food and Drug Administration (FDA) issued a warning regarding the use of acetaminophen, a popular over-the-counter medication used to treat a variety of minor ailments, ...
Continue reading "FDA Urges Warning Against Extra-Strength Acetaminophen" »
Posted on Apr 25, 2014 By The Senators (Ret.) Firm
A former Chief risk officer for the Los Angeles Unified School District recently stepped forward to discuss the school district's alleged destruction of evidence regarding the high-profile ...
Continue reading "LAUSD Faces Allegations for Destroying Evidence in Child Abuse Cases" »
Posted on Apr 25, 2014 By The Senators (Ret.) Firm
Officials from the Oxnard Police Department reported the arrest of an Oxnard teacher earlier this week under suspicion of misdemeanor child annoying. The teacher – 41-year-old Jorge Arellano ...
Continue reading "Oxnard Teacher Arrested on Suspicion of Child Annoyance" »
Posted on Apr 15, 2014 By The Senators (Ret.) Firm
Public records that became available on Tuesday April, 15 th have revealed that the U.S. Food and Drug Administration (FDA) recently issued a warning to the manufacturer of Craze – a once ...
Continue reading "FDA Issues Warning to Manufacturer of Sports Supplement Craze" »
Posted on Apr 11, 2014 By The Senators (Ret.) Firm, LLP
Ten people are confirmed dead after a commercial truck collided with a charter bus carrying high school students in Northern California. One student, a 17-year-old high school senior, remembers waking ...
Continue reading "Ten Dead in College Tour Bus Accident" »
Posted on Apr 9, 2014 By The Senators (Ret.) Firm
A Fullerton junior high school teacher was recently taken into custody on Tuesday, April 8 under suspicion of sexually assaulting and sending sexual text messages to three male students. The female ...
Continue reading "Fullerton Middle School Teacher Faces Multiple Sexual Assault Charges" »
Posted on Apr 8, 2014 By The Senators (Ret.) Firm
Actos® – a diabetes medication and one of the best selling drugs in the U.S. – has been associated with a significant increase in the risk for cancer. Throughout the country, numerous ...
Continue reading "Takeda Pharmaceuticals Ordered to pay $6 Billion for Hiding Actos Cancer Risks" »
Posted on Apr 7, 2014 By The Senators (Ret.) Firm
A new report is calling attention to the need for better regulation of nutritional supplements after OxyElite Pro – a popular dietary supplement – was linked to nearly 100 cases of severe ...
Continue reading "OxyElite Pro Associated with Nearly 100 Cases of Severe Liver Disease, Exposes Need for Better Regulation" »